SWP
ENZ

Stratos Wealth Partners’s Enzo Biochem, Inc. ENZ Stock Holding History

Stratos Wealth Partners’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,403
Closed -$6K – 2581
2018
Q3 		$6K Buy
+1,403
New +$6.37K ﹤0.01% 2404
2018
Q2 		– Sell
-1,431
Closed -$8K – 2664
2018
Q1 		$8K Hold
1,431
– – ﹤0.01% 2435
2017
Q4 		$12K Buy
+1,431
New +$13.7K ﹤0.01% 2101

Other funds holding ENZ

EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Stratos Wealth Partners's ENZ Position: Q4 2018 in Review

Stratos Wealth Partners sold out of Enzo Biochem, Inc. (ENZ) in Q4 2018, closing a stake of 1,403 shares — an estimated $6K sold.

Stratos Wealth Partners first reported a position in ENZ in Q4 2017 and held it in 3 quarters. The position peaked at $12K in Q4 2017. 91 funds tracked by Wall St. Rank hold ENZ as of Q4 2018.

  • Stratos Wealth Partners reported no remaining Enzo Biochem, Inc. position as of Q4 2018 after selling out during the quarter.
  • Stratos Wealth Partners sold 1,403 Enzo Biochem, Inc. shares in Q4 2018, an estimated $6K.
  • Stratos Wealth Partners first reported a position in Enzo Biochem, Inc. in Q4 2017 and held it in 3 quarters.
  • Stratos Wealth Partners's Enzo Biochem, Inc. position peaked at $12K in Q4 2017.
  • 91 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2018.

Based on Stratos Wealth Partners's 13F filing for Q4 2018, filed 8 Feb 2019.